Treatment options for localized scleroderma.

Established

15
Citations
23
Refs
2000
Year
Search Works
Work Details
  • PMID https://pubmed.ncbi.nlm.nih.gov/10751843
  • OpenAlex ID W163035649
  • Type Article
  • Language EN
  • Published 01 Jan 2000
  • Volume 5 (2)
  • Pages 3–5
  • Source PubMed
  • Publisher National Institutes of Health
  • FWCI 0.21
  • Countries 1
  • Institutions 1
  • Added 10 Oct 2025
  • Updated 16 Oct 2026
External Links
OpenAlex Record PubMed Publisher Page
MENU
0

Treatment options for localized scleroderma.

Article 2000 EN

Localized scleroderma, or morphea, is a chronic disease that causes a thickening and induration of the skin. For plaque type morphea, the treatments of choice include super-potent corticosteroids and calcipotriol. For the more generalized forms, as well as the linear forms, UVA is currently the best therapeutic modality. Patients with localized scleroderma are managed by both rheumatologists and d…

15

Citations

23

References

1

Authors

0.21

FWCI

Citations by Year
Last 4 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
1 authors
#AuthorInstitutionsORCID
1 JP Dutz Corresponding University of British Columbia (CA) —
Related Works
10

Data: OpenAlex